risankizumab,ustekinumab
abbvie,janssen
['psoriasis', ' ust ']
 seems underwhelming compared to psoriasis, maybe 1 out of 5 ust failures would respond to rzb induction (which might be a result of the higher induction dose), then at 1y no difference in endoscopic activity and modest improvement in symptoms would switch mechanism personally
Assistant Professor at UCSF, Gastroenterologist, physician-scientist, working toward improved treatments for patients with IBD. My tweets are my own.